Literature DB >> 3210008

Effects of chronic imipramine treatment on glucocorticoid receptor immunoreactivity in various regions of the rat brain. Evidence for selective increases of glucocorticoid receptor immunoreactivity in the locus coeruleus and in 5-hydroxytryptamine nerve cell groups of the rostral ventromedial medulla.

I Kitayama1, A M Janson, A Cintra, K Fuxe, L F Agnati, S O Ogren, A Härfstrand, P Eneroth, J A Gustafsson.   

Abstract

Glucocorticoid receptor (GR) immunoreactivity (IR) was analyzed semi-automatically in the forebrain and in the lower brain stem of male rats treated for two weeks with imipramine (10 mumol/kg). Serum corticosterone and aldosterone levels were determined by means of radioimmunoassay procedures. The microdensitometric analysis demonstrated a selective increase in the GR IR in the nerve cell nuclei of the locus coeruleus (A6), of the ventral part of the reticular gigantocellular nucleus (B3L) and of the nucleus raphae magnus (B 3 M), whereas a small reduction of GR IR was found in the nucleus raphe obscurus (B2). In the morphometric analysis significant increases in the mean profile area of nuclear GR IR, which may be secondary to the increase in GR IR, were observed in the B 3 M. The serum corticosterone and aldosterone levels were not found to be significantly altered. The selective changes of GR IR may reflect the presence of an altered number of GR in these nerve cell groups and/or an altered translocation of GR to the nuclei. It is of substantial interest that these changes were observed in the presence of unchanged serum levels of corticosterone and aldosterone. It seems possible that adaptive changes in monoamine synapses induced by the chronic imipramine treatment may be responsible for the changes in GR IR found in the noradrenaline (NA) and 5-hydroxytryptamine (5-HT) cell bodies, respectively. The present results open up the possibility that chronic imipramine treatment may help to maintain the glucocorticoid receptor function in the locus coeruleus and in the 5-HT cell groups of the rostral ventromedial medulla of depressed patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3210008     DOI: 10.1007/bf01250136

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  23 in total

1.  EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS.

Authors:  A DAHLSTROEM; K FUXE
Journal:  Acta Physiol Scand Suppl       Date:  1964

2.  A new method to quantify catecholamine stores visualized by means of the Falck-Hillarp technique.

Authors:  L F Agnati; F Benfenati; P Cortelli; R D'Alessandro
Journal:  Neurosci Lett       Date:  1978-11       Impact factor: 3.046

3.  Computer-assisted morphometry and microdensitometry of transmitter- identified neurons with special reference to the mesostriatal dopamine pathway. Methodological aspects.

Authors:  L F Agnati; K Fuxe; F Benfenati; I Zini; M Zoli; L Fabbri; A Härfstrand
Journal:  Acta Physiol Scand Suppl       Date:  1984

4.  The specificity of oestrogen receptor in brain, pituitary and uterus.

Authors:  M Ginsburg; N J Maclusky; I D Morris; P J Thomas
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

5.  The unbiased estimation of number and sizes of arbitrary particles using the disector.

Authors:  D C Sterio
Journal:  J Microsc       Date:  1984-05       Impact factor: 1.758

6.  Adrenal steroids affect the norepinephrine-sensitive adenylate cyclase system in the rat limbic forebrain.

Authors:  P L Mobley; F Sulser
Journal:  Eur J Pharmacol       Date:  1980-07-25       Impact factor: 4.432

7.  Studies on neuropeptide Y-catecholamine interactions in the hypothalamus and in the forebrain of the male rat. Relationship to neuroendocrine function.

Authors:  A Härfstrand; K Fuxe; L F Agnati; P Eneroth; I Zini; M Zoli; K Andersson; G von Euler; L Terenius; V Mutt; M Goldstein
Journal:  Neurochem Int       Date:  1986       Impact factor: 3.921

8.  The effects of chronic treatment with the 5-hydroxytryptamine uptake blocker zimelidine on central 5-hydroxytryptamine mechanisms. Evidence for the induction of a low affinity binding site for 5-hydroxytryptamine.

Authors:  K Fuxe; S O Ogren; L F Agnati
Journal:  Neurosci Lett       Date:  1979-08       Impact factor: 3.046

9.  Glucocorticoid receptor immunoreactivity in monoaminergic neurons of rat brain.

Authors:  A Härfstrand; K Fuxe; A Cintra; L F Agnati; I Zini; A C Wikström; S Okret; Z Y Yu; M Goldstein; H Steinbusch
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

10.  Monoclonal antibodies against the rat liver glucocorticoid receptor.

Authors:  S Okret; A C Wikström; O Wrange; B Andersson; J A Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

View more
  11 in total

1.  Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone.

Authors:  Y Dwivedi; H S Rizavi; G N Pandey
Journal:  Neuroscience       Date:  2006-02-24       Impact factor: 3.590

Review 2.  Alterations in neuropeptides in aging and disease. Pathophysiology and potential for clinical intervention.

Authors:  A Leake; I N Ferrier
Journal:  Drugs Aging       Date:  1993 Sep-Oct       Impact factor: 3.923

3.  Antiglucocorticoids as Treatments for Depression : Rationale for Use and Therapeutic Potential.

Authors:  L H Price; R T Malison; C J McDougle; G H Pelton
Journal:  CNS Drugs       Date:  1996-05       Impact factor: 5.749

4.  Increased synaptic availability of norepinephrine following desipramine is not essential for increases in GR mRNA. Short communication.

Authors:  A Eiring; F Sulser
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

5.  Regulation of corticosteroid receptor gene expression in depression and antidepressant action.

Authors:  N Barden
Journal:  J Psychiatry Neurosci       Date:  1999-01       Impact factor: 6.186

Review 6.  Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression.

Authors:  Nicholas Barden
Journal:  J Psychiatry Neurosci       Date:  2004-05       Impact factor: 6.186

Review 7.  Innovative approaches for the treatment of depression: targeting the HPA axis.

Authors:  Fiona Thomson; Mark Craighead
Journal:  Neurochem Res       Date:  2007-10-25       Impact factor: 3.996

Review 8.  Hypothalamic-pituitary-adrenal axis dysregulation and behavioral analysis of mouse mutants with altered glucocorticoid or mineralocorticoid receptor function.

Authors:  Benedict J Kolber; Lindsay Wieczorek; Louis J Muglia
Journal:  Stress       Date:  2008-09       Impact factor: 3.493

9.  Chronic immobilization stress: evidence for decreases of 5-hydroxy-tryptamine immunoreactivity and for increases of glucocorticoid receptor immunoreactivity in various brain regions of the male rat.

Authors:  I Kitayama; A Cintra; A M Janson; K Fuxe; L F Agnati; P Eneroth; M Aronsson; A Härfstrand; H W Steinbush; T J Visser
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

10.  Nobiletin Ameliorates the Deficits in Hippocampal BDNF, TrkB, and Synapsin I Induced by Chronic Unpredictable Mild Stress.

Authors:  Jing Li; Ying Zhou; Bin-Bin Liu; Qing Liu; Di Geng; Lian-Jin Weng; Li-Tao Yi
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-17       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.